)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
KALA BIO
KALA BIO (KALA) investor relations material
KALA BIO Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary15 Apr, 2026
Executive summary
Transitioned from biopharmaceutical R&D to focus on developing an AI infrastructure platform for the biotech industry after discontinuing KPI-012 and MSC-S platform due to failed clinical trial endpoints.
Entered an exclusive license for the Researgency AI research platform in March 2026, aiming to provide on-premises AI solutions for biotech and pharma clients.
Monetization of legacy biologics assets and strategic partnerships remain a parallel priority.
Financial highlights
Net loss for 2025 was $26.98 million, an improvement from $38.51 million in 2024.
Operating expenses decreased to $39.16 million in 2025 from $40.98 million in 2024, driven by lower R&D costs after clinical program discontinuation.
Cash and cash equivalents at year-end 2025 were $7.6 million, down from $51.2 million at year-end 2024.
Accumulated deficit as of December 31, 2025 was $694.9 million.
No revenue-generating commercial products; grant income from CIRM Award ceased after clinical program halt.
Outlook and guidance
Cash runway expected to fund operations into Q1 2027, with additional financing and asset monetization under evaluation.
No near-term revenue expected from AI platform or biologics assets; profitability not anticipated in the foreseeable future.
Strategic focus on AI platform development, customer acquisition, and potential partnerships.
Placebo response analysis in CHASE trial data
Rationale for $7M loan to Minglemint Solutions
Terms of the $55M Younet acquisition option
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from KALA BIO
- Registering 241M+ shares for resale amid Nasdaq compliance risks and leadership changes.KALA
Registration Filing10 Feb 2026 - KPI-012's phase II-B trial for PCED targets a major unmet need, with data expected Q1 2025.KALAH.C. Wainwright 4th Annual Ophthalmology Virtual Conference2 Feb 2026
- All proposals, including director elections and share increase, passed unanimously.KALAAGM 20262 Feb 2026
- KPI-012 nears phase IIb readout for PCED, targeting broad unmet needs in rare eye diseases.KALAJefferies 2024 Global Healthcare Conference1 Feb 2026
- David Lazar's executive experience highlighted as board nomination is updated for the 2025 meeting.KALAProxy Filing26 Jan 2026
- Phase IIb trial for a novel secretome therapy in PCED targets broad approval and billion-dollar market.KALAPiper Sandler 36th Annual Healthcare Conference11 Jan 2026
- Settlements with Baker Bros. and LifeSci increased outstanding shares to 27.8 million.KALAProxy Filing6 Jan 2026
- Proxy seeks approval for director elections, share issuance, capital changes, and auditor ratification.KALAProxy Filing30 Dec 2025
- Late-stage trial for a stem cell-based eye drop targets broad PCED market with imminent data.KALAH.C. Wainwright 27th Annual Global Investment Conference27 Dec 2025
Next KALA BIO earnings date
Q1 202619 May, 2026
KALA BIO
Next KALA BIO earnings date
Q1 202619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage